• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过脑心肌炎病毒对肾细胞癌进行溶瘤靶向治疗。

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus.

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

出版信息

EMBO Mol Med. 2010 Jul;2(7):275-88. doi: 10.1002/emmm.201000081.

DOI:10.1002/emmm.201000081
PMID:20623734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3377327/
Abstract

Apoptosis is a fundamental host defence mechanism against invading microbes. Inactivation of NF-kappaB attenuates encephalomyocarditis virus (EMCV) virulence by triggering rapid apoptosis of infected cells, thereby pre-emptively limiting viral replication. Recent evidence has shown that hypoxia-inducible factor (HIF) increases NF-kappaB-mediated anti-apoptotic response in clear-cell renal cell carcinoma (CCRCC) that commonly exhibit hyperactivation of HIF due to the loss of its principal negative regulator, von Hippel-Lindau (VHL) tumour suppressor protein. Here, we show that EMCV challenge induces a strong NF-kappaB-dependent gene expression profile concomitant with a lack of interferon-mediated anti-viral response in VHL-null CCRCC, and that multiple established CCRCC cell lines, as well as early-passage primary CCRCC cultured cells, are acutely susceptible to EMCV replication and virulence. Functional restoration of VHL or molecular suppression of HIF or NF-kappaB dramatically reverses CCRCC cellular susceptibility to EMCV-induced killing. Notably, intratumoural EMCV treatment of CCRCC in a murine xenograft model rapidly regresses tumour growth. These findings provide compelling pre-clinical evidence for the usage of EMCV in the treatment of CCRCC and potentially other tumours with elevated HIF/NF-kappaB-survival signature.

摘要

细胞凋亡是宿主抵抗入侵微生物的基本防御机制。NF-κB 的失活通过触发感染细胞的快速凋亡来减弱脑心肌炎病毒 (EMCV) 的毒力,从而预先限制病毒复制。最近的证据表明,缺氧诱导因子 (HIF) 增加了 NF-κB 介导的抗凋亡反应,在常因主要负调节剂 von Hippel-Lindau (VHL) 肿瘤抑制蛋白缺失而导致 HIF 过度激活的透明细胞肾细胞癌 (CCRCC) 中更是如此。在这里,我们表明 EMCV 挑战会诱导强烈的 NF-κB 依赖性基因表达谱,同时缺乏干扰素介导的抗病毒反应在 VHL 缺失的 CCRCC 中,并且多个已建立的 CCRCC 细胞系以及早期传代的原发性 CCRCC 培养细胞对 EMCV 复制和毒力非常敏感。VHL 的功能恢复或 HIF 或 NF-κB 的分子抑制可显著逆转 CCRCC 细胞对 EMCV 诱导杀伤的敏感性。值得注意的是,在 CCRCC 的小鼠异种移植模型中,肿瘤内 EMCV 治疗可迅速使肿瘤生长消退。这些发现为 EMCV 在 CCRCC 及其他可能具有升高的 HIF/NF-κB 存活特征的肿瘤的治疗中的应用提供了令人信服的临床前证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/334da14badf7/emmm0002-0275-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/b1bc2757bb86/emmm0002-0275-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/ad1f4d61d1ac/emmm0002-0275-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/1ff81328b83f/emmm0002-0275-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/d246b1d32559/emmm0002-0275-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/41f816593950/emmm0002-0275-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/334da14badf7/emmm0002-0275-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/b1bc2757bb86/emmm0002-0275-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/ad1f4d61d1ac/emmm0002-0275-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/1ff81328b83f/emmm0002-0275-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/d246b1d32559/emmm0002-0275-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/41f816593950/emmm0002-0275-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f41/3377327/334da14badf7/emmm0002-0275-f6.jpg

相似文献

1
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus.通过脑心肌炎病毒对肾细胞癌进行溶瘤靶向治疗。
EMBO Mol Med. 2010 Jul;2(7):275-88. doi: 10.1002/emmm.201000081.
2
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.von Hippel-Lindau 肿瘤抑制蛋白通过组蛋白去甲基酶 JARID1C 调节基因表达和肿瘤生长。
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
3
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.铁螯合对透明细胞肾细胞癌的抑制作用及其对 VHL 失活的依赖性。
Free Radic Biol Med. 2019 Mar;133:295-309. doi: 10.1016/j.freeradbiomed.2018.12.013. Epub 2018 Dec 13.
4
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.人肾癌细胞通过激活p38丝裂原活化蛋白激酶/核因子κB/核因子κB抑制蛋白α通路对新城疫病毒感染作出反应。
Cell Oncol (Dordr). 2015 Aug;38(4):279-88. doi: 10.1007/s13402-015-0229-5. Epub 2015 May 1.
5
Targeting renal cell carcinoma with a HIF-2 antagonist.用低氧诱导因子-2拮抗剂靶向治疗肾细胞癌。
Nature. 2016 Nov 3;539(7627):112-117. doi: 10.1038/nature19796. Epub 2016 Sep 5.
6
Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth.Physapubescin 通过下调 HIF-2α 选择性诱导 VHL 缺失的肾细胞癌细胞凋亡,并抑制肿瘤生长。
Sci Rep. 2016 Sep 1;6:32582. doi: 10.1038/srep32582.
7
Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.VHL缺失和缺氧可引发透明细胞肾细胞癌中PAX2的上调。
Clin Cancer Res. 2009 May 15;15(10):3297-304. doi: 10.1158/1078-0432.CCR-08-2779. Epub 2009 Apr 28.
8
A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization.一种新型的与 pVHL 无关但依赖于 NEMO 的肾癌通路促进 HIF 稳定。
Oncogene. 2016 Jun 16;35(24):3125-38. doi: 10.1038/onc.2015.400. Epub 2015 Oct 26.
9
[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].[缺氧诱导因子-1、2α在散发性透明细胞肾细胞癌中的表达及其与冯·希佩尔-林道基因变异的关系]
Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3.
10
In Silico Exploration of AHR-HIF Pathway Interplay: Implications for Therapeutic Targeting in ccRCC.AHR-HIF 通路相互作用的计算机探索:在 ccRCC 治疗靶点中的意义。
Genes (Basel). 2024 Sep 5;15(9):1167. doi: 10.3390/genes15091167.

引用本文的文献

1
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.胱硫醚γ-裂解酶介导的缺氧诱导因子1α表达驱动透明细胞卵巢癌进展。
J Pathol. 2025 Jul;266(3):352-367. doi: 10.1002/path.6433. Epub 2025 May 15.
2
Innovative strategies in genitourinary cancer: the role of oncolytic viruses.泌尿生殖系统癌症的创新策略:溶瘤病毒的作用
Front Oncol. 2024 Oct 11;14:1461324. doi: 10.3389/fonc.2024.1461324. eCollection 2024.
3
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy.

本文引用的文献

1
Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex.通过工程化的 VHL 肿瘤抑制因子复合物实现缺氧诱导因子-α的非依赖氧降解。
EMBO Mol Med. 2009 Apr;1(1):66-78. doi: 10.1002/emmm.200900004.
2
Biopsy of a renal mass: where are we now?肾肿物活检:我们目前的情况如何?
Curr Opin Urol. 2009 Sep;19(5):447-53. doi: 10.1097/MOU.0b013e32832f0d5a.
3
Current animal models: transgenic animal models for the study of measles pathogenesis.当前的动物模型:用于研究麻疹发病机制的转基因动物模型。
教程:用于癌症免疫疗法的溶瘤病毒的设计、生产和测试。
Nat Protoc. 2024 Sep;19(9):2540-2570. doi: 10.1038/s41596-024-00985-1. Epub 2024 May 20.
4
A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.一种有前途的基于自然杀伤细胞的模型和列线图,用于预测透明细胞肾细胞癌的预后。
Eur J Med Res. 2024 Jan 24;29(1):73. doi: 10.1186/s40001-024-01659-0.
5
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.新型冠状病毒感染与肾癌之间联系的新见解
Life (Basel). 2023 Dec 28;14(1):52. doi: 10.3390/life14010052.
6
Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma.新兴免疫疗法在晚期透明细胞肾细胞癌中的应用。
Cells. 2023 Dec 22;13(1):34. doi: 10.3390/cells13010034.
7
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune Mice.全身给药的靶向性溶瘤单纯疱疹病毒在未免疫和HSV预免疫小鼠中的疗效——清除率和生物分布
Cancers (Basel). 2023 Aug 10;15(16):4042. doi: 10.3390/cancers15164042.
8
Developing Picornaviruses for Cancer Therapy.开发用于癌症治疗的小核糖核酸病毒。
Cancers (Basel). 2019 May 16;11(5):685. doi: 10.3390/cancers11050685.
9
NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.溶瘤病毒靶向肿瘤细胞中的NF-κB信号传导——治疗前景
Cancers (Basel). 2018 Nov 8;10(11):426. doi: 10.3390/cancers10110426.
10
Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.新城疫病毒通过不依赖VHL和p53的蛋白酶体途径降解缺氧诱导因子-1α。
J Gen Virol. 2016 Dec;97(12):3174-3182. doi: 10.1099/jgv.0.000623. Epub 2016 Oct 6.
Curr Top Microbiol Immunol. 2009;330:111-27. doi: 10.1007/978-3-540-70617-5_6.
4
Beyond the hypoxia-inducible factor-centric tumour suppressor model of von Hippel-Lindau.超越以缺氧诱导因子为中心的冯·希佩尔-林道肿瘤抑制模型。
Curr Opin Oncol. 2008 Jan;20(1):83-9. doi: 10.1097/CCO.0b013e3282f310de.
5
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.pVHL作为衔接蛋白,促进CK2对NF-κB激动剂Card9的抑制性磷酸化。
Mol Cell. 2007 Oct 12;28(1):15-27. doi: 10.1016/j.molcel.2007.09.010.
6
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.VHL通过缺氧诱导因子(HIF)介导的SIP1和蜗牛蛋白调节,促进依赖E2框的E-钙黏蛋白转录。
Mol Cell Biol. 2007 Jan;27(1):157-69. doi: 10.1128/MCB.00892-06. Epub 2006 Oct 23.
7
Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.Mdm2介导的TAp73的NEDD8修饰调节其反式激活功能。
J Biol Chem. 2006 Nov 10;281(45):34096-103. doi: 10.1074/jbc.M603654200. Epub 2006 Sep 14.
8
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.VHL缺失赋予缺氧诱导因子(HIF)依赖性抗水疱性口炎病毒能力:HIF在抗病毒反应中的作用
J Virol. 2006 Nov;80(21):10712-23. doi: 10.1128/JVI.01014-06. Epub 2006 Aug 23.
9
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization.一项使用两步脱敏法静脉注射溶瘤病毒PV701的1期临床研究。
Clin Cancer Res. 2006 Apr 15;12(8):2555-62. doi: 10.1158/1078-0432.CCR-05-2038.
10
The polypyrimidine tract-binding protein stimulates HIF-1alpha IRES-mediated translation during hypoxia.多嘧啶序列结合蛋白在缺氧期间刺激缺氧诱导因子-1α内部核糖体进入位点介导的翻译。
Nucleic Acids Res. 2005 Dec 7;33(21):6884-94. doi: 10.1093/nar/gki1000. Print 2005.